Enclosed the Annual Secretarial Compliance Report dated 13-05-2026 for the Financial Year 2025-2026 issued by our Secretarial auditor CS Ajit Sathe, Proprietor of M/s. A.Y.Sathe & Co, Company ....
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indoco Remedies Ltd has filed its Annual Secretarial Compliance Report for the financial year ended 31st March 2026, as mandated under SEBI Regulation 24A(2). The report was issued by CS Ajit Sathe of M/s A.Y. Sathe & Co., Practicing Company Secretaries, dated 13th May 2026. The secretarial auditor examined compliance across 13 areas including SEBI Listing Obligations, Insider Trading Regulations, Depositories Regulations, and Related Party Transactions. All compliance checkpoints returned a 'Yes' or 'NA' status with no deviations, violations, or penalties reported. No actions were taken by SEBI or stock exchanges during the review period. The company confirmed compliance with Secretarial Standards issued by ICSI, maintenance of functional website with timely disclosures, preservation of documents as per policy, and performance evaluation of the Board and committees.
This is a clean compliance report indicating full adherence to SEBI regulatory requirements for FY 2025-26. The absence of any violations or adverse observations from the secretarial auditor is a positive signal for investors regarding the company's governance standards. No direct impact on stock price expected.